Inventiva IVA
NASDAQ IVA
$3.90 +0.07 (+1.69%)
As of: Nov 10, 2026 · 3:48 PM EST

Inventiva (IVA) EBITDA Margin (2020 - 2021)

Updated

Inventiva (IVA) reported EBITDA Margin of -3073.61% for FY2025, down 2069.48 percentage points from -1004.13% in FY2024.

Analysis

Inventiva (IVA) EBITDA Margin (2020 - 2021) Analysis & Trends

Dating back to FY2018, Inventiva's EBITDA Margin record includes 8 years.

  • EBITDA Margin has declined for three consecutive years, though with a five-year change of +4407.57 percentage points (FY2020 to FY2025).
  • The FY2025 figure ranks as the lowest annual EBITDA Margin since FY2020.
  • According to Business Quant data, EBITDA Margin came in at -1004.13% in FY2024 (-431.32 pp), -572.81% in FY2023 (-117.83 pp), -454.98% in FY2022 (+818.32 pp) and -1273.30% in FY2021 (+6207.89 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 54.65%
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 32.68%
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 46.88%
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 40.75%
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 46.62%
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 50.63%
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 42.49%
10 Inventiva 732.26 Mn 182.20 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 -20,667.69%
Mar 31, 2021 -13,024.32%
Jun 30, 2020 -11,527.03%
Mar 31, 2020 -7,434.48%
API Access

Inventiva EBITDA Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda-margin&ticker=IVA&period=max&api_key=YOUR_API_KEY